Title: Achievement Rates of Japan Atherosclerosis Society Guidelines 2007 <scp>LDL</scp>‐Cholesterol Goals with Rosuvastatin or Atorvastatin in Patients Who Had Not Achieved Their Goal with Atorvastatin
Abstract: Summary Background The Japan Atherosclerosis Society's 2007 Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases ( JAS 2007 GL ) advocate reducing LDL cholesterol ( LDL ‐C) to target levels in patients with dyslipidemia, but achievement rates are frequently unsatisfactory even in the presence of lipid‐lowering therapy. This multicenter, open‐label, randomized, parallel‐group study compared the efficacy of rosuvastatin and atorvastatin on JAS 2007 GL LDL ‐C goals in Japanese patients not achieving their target goal with atorvastatin treatment. Methods The study involved 20 clinical institutes in Japan (Kishiwada Atherosclerosis Prevention Study [ KAPS ] Group). Patients with category II or III risk of coronary artery disease ( CAD ), or those with a history of CAD (secondary prevention), who had not achieved their JAS 2007 GL LDL ‐C goals during treatment with atorvastatin for at least 4 weeks were switched either to rosuvastatin 5 mg/day (from atorvastatin 10 mg/day) or rosuvastatin 10 mg/day (from atorvastatin 20 mg/day) (n = 75) or continued to receive atorvastatin (n = 77). The primary endpoint was achievement of LDL ‐C goals at 3 months. The main secondary endpoint was achievement of LDL ‐C goal + high‐sensitivity C‐reactive protein level <1.0 mg/L at 3 months. Results Achievement rates for the primary endpoint were 49.3% in the rosuvastatin group and 31.7% in the atorvastatin group ( P = 0.022). Achievement rates for the main secondary endpoint were 40.0% in the rosuvastatin group and 20.8% in the atorvastatin group ( P = 0.010). Rosuvastatin and atorvastatin were both well tolerated in this study. Conclusions Rosuvastatin is a useful treatment option for Japanese patients who are not achieving their JAS 2007 GL LDL ‐C goal with atorvastatin.
Publication Year: 2014
Publication Date: 2014-04-23
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 11
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot